Amarin Corp Plcuk (AMRN) Shares Issued (2010 - 2024)
Amarin Corp Plcuk (AMRN) reported Shares Issued of -$112000.0 for Q4 2024, down 224.44% year-over-year from $90000.0 in Q1 2024, and down 200.23% quarter-over-quarter from $111740.0 in Q2 2024.
Amarin Corp Plcuk (AMRN) Shares Issued (2010 - 2024) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 15 years of Shares Issued data on file, last reported at -$112000.0 in Q4 2024.
- Shares Issued for Q4 2024 came in at -$112000.0, down 224.44% year-over-year; the trailing twelve-month figure through Dec 2025 was -$112000.0 (down 1220.0% YoY), and the FY2024 annual result was $10000.0, down 96.97% from the prior year.
- Shares Issued fell to -$112000.0 in Q4 2024 per AMRN's latest filing, from $111740.0 in the prior quarter.
- Over five years, Shares Issued peaked at $2.1 million in Q1 2021 and troughed at -$1.6 million in Q2 2023.
- A 5-year average of $224833.3 and a median of $60000.0 in 2022 frame the typical range for Shares Issued.
- On a YoY basis, Shares Issued climbed as much as 6136.67% in 2023 and fell as far as 8684.21% in 2023.
- A 5-year view of Shares Issued shows it stood at $1.1 million in 2020, then tumbled by 187.02% to -$965000.0 in 2021, then soared by 70.67% to -$283000.0 in 2022, then jumped by 131.8% to $90000.0 in 2023, then tumbled by 224.44% to -$112000.0 in 2024.
- Business Quant data shows AMRN's Shares Issued at -$112000.0 in Q4 2024, $111740.0 in Q2 2024, and $10260.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 10.79 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 1.17 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | - |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 157.00 Mn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 166.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -112,000.00 |
| Dec 31, 2024 | -112,000.00 |
| Jun 30, 2024 | 111,740.00 |
| Jun 30, 2024 | 111,740.00 |
| Mar 31, 2024 | 10,260.00 |
| Mar 31, 2024 | 10,260.00 |
| Dec 31, 2023 | 90,000.00 |
| Dec 31, 2023 | 90,000.00 |
| Jun 30, 2023 | -1.63 Mn |
| Jun 30, 2023 | -1.63 Mn |
| Mar 31, 2023 | 1.87 Mn |
| Mar 31, 2023 | 1.87 Mn |
| Dec 31, 2022 | -283,000.00 |
| Dec 31, 2022 | -283,000.00 |
| Sep 30, 2022 | 334,000.00 |
| Sep 30, 2022 | 334,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Jun 30, 2022 | 19,000.00 |
| Mar 31, 2022 | 30,000.00 |
| Mar 31, 2022 | 30,000.00 |